David Weaver
-
Vanderbilt-Ancora partnership advances research for rare form of epilepsy
Research in the Weaver lab leads to discoveries that help secure partnership with Ancora Innovation LLC. “Vanderbilt is at the forefront of genetic research. By understanding the genetic causes of disease opens exciting new opportunities to develop drugs to treat them more effectively,” said Matt Nelson, vice president, genetics and genomics, 3DC at Deerfield Management. Read MoreOct 27, 2022
-
Twelve faculty members named as 2018 Chancellor Faculty Fellows
Twelve outstanding faculty members from across the university have been named to the 2018 class of Chancellor Faculty Fellows. The class comprises highly accomplished, recently tenured faculty from all corners of campus. Read MoreJan 18, 2018
-
VU, GlaxoSmithKline team to develop novel treatments for severe obesity
Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity. Read MoreFeb 11, 2013
-
VU researcher has personal motive for investigating malaria
Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes. Read MoreFeb 3, 2012
-
Cancer study seeks clues to halting metastasis’ march
Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth. Read MoreAug 10, 2011